215 related articles for article (PubMed ID: 33887267)
1. Anticancer potential of cardiac glycosides and steroid-azole hybrids.
Hou Y; Shang C; Meng T; Lou W
Steroids; 2021 Jul; 171():108852. PubMed ID: 33887267
[TBL] [Abstract][Full Text] [Related]
2. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
3. Current development of pyrazole-azole hybrids with anticancer potential.
Zhang S; Ye Y; Zhang Q; Luo Y; Wang ZC; Wu YZ; Zhang XP; Yi C
Future Med Chem; 2023 Aug; 15(16):1527-1548. PubMed ID: 37610862
[TBL] [Abstract][Full Text] [Related]
4. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in isatin hybrids as potential anticancer agents.
Ding Z; Zhou M; Zeng C
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021).
Feng LS; Su WQ; Cheng JB; Xiao T; Li HZ; Chen DA; Zhang ZL
Arch Pharm (Weinheim); 2022 Jun; 355(6):e2200051. PubMed ID: 35385159
[TBL] [Abstract][Full Text] [Related]
8. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
9. Nature-derived anticancer steroids outside cardica glycosides.
Xiao J; Gao M; Fei B; Huang G; Diao Q
Fitoterapia; 2020 Nov; 147():104757. PubMed ID: 33069834
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
11. Tetrazole hybrids with potential anticancer activity.
Zhang J; Wang S; Ba Y; Xu Z
Eur J Med Chem; 2019 Sep; 178():341-351. PubMed ID: 31200236
[TBL] [Abstract][Full Text] [Related]
12. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Xu Z; Zhao SJ; Liu Y
Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
[TBL] [Abstract][Full Text] [Related]
13. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F
Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133
[TBL] [Abstract][Full Text] [Related]
14. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
15. Azole-Pyrimidine Hybrid Anticancer Agents: A Review of Molecular Structure, Structure Activity Relationship, and Molecular Docking.
Eze CC; Ezeokonkwo AM; Ugwu ID; Eze UF; Onyeyilim EL; Attah IS; Okonkwo IV
Anticancer Agents Med Chem; 2022 Aug; 22(16):2822-2851. PubMed ID: 35306990
[TBL] [Abstract][Full Text] [Related]
16. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative Activity of 8-methoxy Ciprofloxacin-Hydrozone/Acylhydrazone Scaffolds.
Wang LP; Xu Z; Deng GY; Xu SL
Curr Top Med Chem; 2020; 20(21):1911-1915. PubMed ID: 32493190
[TBL] [Abstract][Full Text] [Related]
18. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.
Nepali K; Sharma S; Sharma M; Bedi PM; Dhar KL
Eur J Med Chem; 2014 Apr; 77():422-87. PubMed ID: 24685980
[TBL] [Abstract][Full Text] [Related]
19. Recent updates on 1,2,3-, 1,2,4-, and 1,3,5-triazine hybrids (2017-present): The anticancer activity, structure-activity relationships, and mechanisms of action.
Dong G; Jiang Y; Zhang F; Zhu F; Liu J; Xu Z
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200479. PubMed ID: 36372519
[TBL] [Abstract][Full Text] [Related]
20. Indole Alkaloids, Synthetic Dimers and Hybrids with Potential In Vivo Anticancer Activity.
Song F; Bian Y; Liu J; Li Z; Zhao L; Fang J; Lai Y; Zhou M
Curr Top Med Chem; 2021; 21(5):377-403. PubMed ID: 32901583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
